Hinge Health, Inc. HNGE
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 49.86% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.86% | -- | -- | -- | -- |
| Cost of Revenue | 0.53% | -- | -- | -- | -- |
| Gross Profit | 63.11% | -- | -- | -- | -- |
| SG&A Expenses | -34.80% | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 96.25% | -- | -- | -- | -- |
| Total Operating Expenses | -40.15% | -- | -- | -- | -- |
| Operating Income | 127.17% | -- | -- | -- | -- |
| Income Before Tax | 131.18% | -- | -- | -- | -- |
| Income Tax Expenses | -2,646.58% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 131.56% | -- | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 131.56% | -- | -- | -- | -- |
| EBIT | 127.17% | -- | -- | -- | -- |
| EBITDA | 127.80% | -- | -- | -- | -- |
| EPS Basic | 164.67% | -- | -- | -- | -- |
| Normalized Basic EPS | 120.82% | -- | -- | -- | -- |
| EPS Diluted | 120.06% | -- | -- | -- | -- |
| Normalized Diluted EPS | 117.88% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 109.45% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 46.96% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |